157 related articles for article (PubMed ID: 30799772)
1. Differential diagnosis between bone relapse of breast cancer and lambda light chain multiple myeloma: role of the clinical biochemist.
Mastroianni A; Panella R; Morelli D
Tumori; 2019 Dec; 105(6):NP17-NP19. PubMed ID: 30799772
[TBL] [Abstract][Full Text] [Related]
2. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Bianchi G; Richardson PG; Anderson KC
J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
[TBL] [Abstract][Full Text] [Related]
3. Quantification by Ultrafiltration and Immunofixation Electrophoresis Testing for Monoclonal Serum Free Light Chains.
Singh G; Bollag R
Lab Med; 2020 Nov; 51(6):592-600. PubMed ID: 32285117
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
[TBL] [Abstract][Full Text] [Related]
5. A triclonal gammopathy in a relapsing multiple myeloma patient, detected by immunosubtraction method.
Aksungar FB; Ayer M; Serteser M; Coskun A; Unsal I
Ann Clin Biochem; 2014 Sep; 51(Pt 5):606-10. PubMed ID: 24361990
[TBL] [Abstract][Full Text] [Related]
6. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
Cao F; Zhang R; Xu L; Liu M; Yuan Y
Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
[TBL] [Abstract][Full Text] [Related]
7. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
[TBL] [Abstract][Full Text] [Related]
8. Lambda light chain myeloma presenting as nodular hepatic lesion: a clinical rarity.
Pal S; Chattopadhyay B; Chatterjee A; Bhattacharya B
J Cancer Res Ther; 2014; 10(1):191-3. PubMed ID: 24762510
[TBL] [Abstract][Full Text] [Related]
9. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
10. [Immunoglobulin D lambda multiple myeloma: a case report].
Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885
[TBL] [Abstract][Full Text] [Related]
11. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
[TBL] [Abstract][Full Text] [Related]
12. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
Wu CK; Yang AH; Lai HC; Lin BS
BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
[TBL] [Abstract][Full Text] [Related]
13. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.
Dejoie T; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2016 Mar; 101(3):356-62. PubMed ID: 26635032
[TBL] [Abstract][Full Text] [Related]
16. The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma.
Warnnissorn AN; Treetipsatit J; Limvorapitak W
Hematology; 2020 Dec; 25(1):292-298. PubMed ID: 32772824
[No Abstract] [Full Text] [Related]
17. [A case of multiple plasmacytomas of the bone].
Matsui Y; Tanaka S; Sasaki Y; Kitaichi M; Izumi T; Ohshima S
Bull Chest Dis Res Inst Kyoto Univ; 1989 Mar; 22(1-2):4-10. PubMed ID: 2515898
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
19. Multiple myeloma presenting as hepatic nodular lesion.
de Vos M; Druez P; Nicaise M; Ngendahayo P; Sinapi I; Mineur P
Acta Clin Belg; 2012; 67(5):378-80. PubMed ID: 23189550
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
